0001209191-19-037487.txt : 20190617 0001209191-19-037487.hdr.sgml : 20190617 20190617184118 ACCESSION NUMBER: 0001209191-19-037487 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190613 FILED AS OF DATE: 20190617 DATE AS OF CHANGE: 20190617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FETZER OLIVER CENTRAL INDEX KEY: 0001219018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31161 FILM NUMBER: 19902322 MAIL ADDRESS: STREET 1: AUXILIUM PHARMACEUTICALS, INC. STREET 2: 40 VALLEY STREAM PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001080709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232908305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6154 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-453-7200 MAIL ADDRESS: STREET 1: 6154 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-13 0 0001080709 ARENA PHARMACEUTICALS INC ARNA 0001219018 FETZER OLIVER C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 1 0 0 0 Common Stock 2019-06-13 4 A 0 2654 0.00 A 5704 D Common Stock 2019-06-14 4 S 0 1495 55.8791 D 4209 D Common Stock 2019-06-14 4 S 0 30 56.64 D 4179 D Stock Option (right to buy) 56.50 2019-06-13 4 A 0 5000 0.00 A 2026-06-13 Common Stock 5000 5000 D The amount represents restricted stock units that vest in full on the earliest of June 13, 2020, or the date of Arena's next annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting of the restricted stock units. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.49 to $56.48, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4. The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 13, 2019, and are exercisable once vested. /s/ Veronica Vallejo, as Attorney-in-Fact 2019-06-17